Electronic health records reveals resilience patterns of cardiovascular disease in Basque centenarians.
Sara Cruces-Salguero, Igor Larrañaga, Javier Mar, Ander Matheu
Kernaussage
Centenarians exhibit delayed onset, reduced severity of some cardiovascular diseases, fewer comorbidities, lower medication use, extended survival, and more favorable biological recovery trajectories compared to non-centenarians, suggesting resilience mechanisms contributing to longevity.
Abstract
Cardiovascular diseases (CVDs) are the leading cause of death worldwide. Although their prevalence increases with age, their impact on centenarians remains poorly understood. We analyzed Electronic Health Records (EHRs) to assess the incidence and effect of CVDs in centenarians (n = 649) and non-centenarians (n = 62,753) in the Basque Country. Descriptive statistics were applied to discern differences between the two population groups in terms of prevalence, number of diagnoses, and treatments. Survival analysis was performed through Kaplan-Meier estimator. Trajectories of laboratory parameters were explored through non-linear mixed models (NLMMs). Centenarians had lower incidence of severe conditions such as ischemic heart disease, despite overall CVD incidence being similar between groups. Survival analyses revealed extended longevity in centenarians after both first and last CVD diagnosis. Biomarker trajectories suggested favorable biological profiles with greater resilience and faster recovery in centenarians. Despite experiencing CVDs, centenarians demonstrate delayed onset, reduced severity, and more favorable biological recovery compared to non-centenarians. These findings indicate potential resilience mechanisms that may contribute to healthy ageing.
Kein medizinischer Rat. Die dargestellten Studien dienen der wissenschaftlichen Information und ersetzen keine ärztliche Beratung. Bei gesundheitlichen Fragen wende dich an eine approbierte Ärztin oder einen Arzt.
Quelle: PubMed Central / National Library of Medicine (NLM). Apollion steht in keiner Verbindung mit NLM und wird von NLM nicht empfohlen. Evidenzgrade bewerten die methodische Studienqualität — nicht die inhaltliche Richtigkeit.
Lizenz: CC BY — Inhalte werden ausschließlich aus Open-Access-Quellen mit kommerziell nutzbaren Lizenzen (CC0, CC BY, CC BY-SA) indexiert.